Nuvo Pharms Inc Drug Patent Portfolio
Nuvo Pharms Inc owns 1 orange book drug protected by 4 US patents Given below is the list of Nuvo Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8546450 | Treatment of pain with topical diclofenac compounds | 09 Aug, 2030 | Active |
| US8217078 | Treatment of pain with topical diclofenac | 10 Jul, 2029 | Active |
| US8618164 | Treatment of pain with topical diclofenac compounds | 10 Jul, 2029 | Active |
| US8741956 | Treatment of pain with topical diclofenac | 10 Jul, 2029 | Active |
Latest Legal Activities on Nuvo Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Nuvo Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 24 Jun, 2024 | US9339552 (Litigated) |
|
Expire Patent
Critical
| 24 Jun, 2024 | US9339551 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 15 Apr, 2024 | US8252838 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Apr, 2024 | US9415029 |
|
Maintenance Fee Reminder Mailed
Critical
| 26 Feb, 2024 | US8217078 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 19 Feb, 2024 | US9375412 |
|
Maintenance Fee Reminder Mailed
Critical
| 12 Feb, 2024 | US9370501 |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Jan, 2024 | US9339551 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 Jan, 2024 | US9339552 (Litigated) |
|
Expire Patent
Critical
| 23 Oct, 2023 | US9132110 (Litigated) |
|
Expire Patent
Critical
| 18 Sep, 2023 | US9101591 (Litigated) |
|
Expire Patent
Critical
| 07 Aug, 2023 | US9066913 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Jun, 2023 | US9220784 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 08 May, 2023 | US9132110 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 27 Apr, 2023 | US9168304 (Litigated) |
Nuvo Pharms Inc's Family Patents
Nuvo Pharms Inc Drug List
Given below is the complete list of Nuvo Pharms Inc's drugs and the patents protecting them.
1. Pennsaid
Pennsaid is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8546450 | Treatment of pain with topical diclofenac compounds |
09 Aug, 2030
(5 years from now)
| Active |
| US8217078 | Treatment of pain with topical diclofenac |
10 Jul, 2029
(4 years from now)
| Active |
| US8618164 | Treatment of pain with topical diclofenac compounds |
10 Jul, 2029
(4 years from now)
| Active |
| US8741956 | Treatment of pain with topical diclofenac |
10 Jul, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pennsaid's drug page